CRP and breast cancer: To conclude, the findings of this case-control study nested in the EPIC-Varese cohort suggest that high levels of CRP and low levels of adiponectin may increase the risk of postmenopausal breast cancer, while high levels of TNF-α and IL-6, and low levels of leptin may increase breast cancer risk among premenopausal women.